Rare Cancers Act 2026
A Bill to make provision to incentivise research and investment into the treatment of rare types of cancer; and for connected purposes.
- Status
- Act · Royal Assent 5 Mar 2026
- Introduced in
- the Commons
- Now in
- the Unassigned
- First sitting
- 16 October 2024
- Royal Assent
- 5 March 2026
- Source
- bills.parliament.uk
Stages
| Date | House | Stage |
|---|---|---|
| 16 Oct 2024 | Commons | 1st reading |
| 14 Mar 2025 | Commons | 2nd reading |
| 30 Jun 2025 | Commons | Money resolution |
| 2 Jul 2025 | Commons | Committee stage |
| 11 Jul 2025 | Commons | Report stage |
| 11 Jul 2025 | Commons | 3rd reading |
| 14 Jul 2025 | Lords | 1st reading |
| 16 Jan 2026 | Lords | 2nd reading |
| 11 Feb 2026 | Lords | Order of Commitment discharged |
| 27 Feb 2026 | Lords | 3rd reading |
| 5 Mar 2026 | Unassigned | Royal Assent |
Divisions in the Commons
Linked by this site from the division title (computed, not published by Parliament). Votes on the voices leave no individual vote and do not appear.
No division is linked to this bill.